• Study on the Safety and Effectiveness of Hydroxypropylbetadex and Miglustat for Patients with Niemann-Pick Disease Type C1

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Poland Spain

  • Study on the Effects of Maridebart Cafraglutide for Adults with Type 2 Diabetes

    Not recruiting

    2 1
    Investigated diseases:
    Investigated drugs:
    Austria Greece Hungary Italy Poland Romania +2

  • Study on the Effectiveness and Safety of Bimekizumab and Risankizumab in Adults with Active Psoriatic Arthritis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Czechia Germany Hungary Poland Spain

  • Study on Birtamimab and Bortezomib for Patients with Advanced Light Chain Amyloidosis

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +8

  • Study on Ibrutinib and Drug Combination for Patients with Generalized Mantle Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Belgium Czechia Denmark Finland Germany Italy +6

  • Study on the Effects of Povetacicept for Adults with IgA Nephropathy

    Not recruiting

    3 1
    Investigated diseases:
    Austria Belgium Croatia Czechia Denmark Estonia +13

  • Study on Durvalumab for Patients with Completely Removed Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria France Hungary Italy The Netherlands Poland +2

  • Study on EYE103 and Ranibizumab for Patients with Diabetic Macular Edema

    Not recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria Croatia Czechia France Germany Hungary +6

  • Study on Balstilimab for Patients with Advanced Non-Melanoma Skin Cancers

    Not recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

  • Study of empagliflozin to improve exercise capacity in patients with hypertrophic cardiomyopathy

    Not recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Poland

powered by